Skip to main content

Rukobia Prices, Coupons, Copay Cards & Patient Assistance

Rukobia (fostemsavir) is a member of the miscellaneous antivirals drug class and is commonly used for HIV Infection.

The cost for Rukobia 600 mg oral tablet, extended release is around $9,497 for a supply of 60 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Rukobia is available as a brand name drug only, a generic version is not yet available. View generic Rukobia availability for more details.

Rukobia prices

Oral Tablet, Extended Release

Quantity Per unit Price
60 $158.28 $9,496.98

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Rukobia Coupons, Copay Cards and Rebates

Rukobia offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Rukobia ViiVConnect Savings Card

Eligible commercially insured patients pay $0 per prescription with savings of up to $7500 per year with no monthly limit; for additional information contact the program at 844-588-3288.

Applies to:
Rukobia
Number of uses:
per prescription per year

Form more information phone: 844-588-3288 or Visit website

Rukobia ViiVConnect Rebate

Eligible commercially insured patients may submit a rebate if the pharmacy does not accept the Savings Card and the patient paid in full for their prescription; rebate may be completed online or by downloading and mailing in the rebate form; for additional information contact the program at 866-747-1170.

Applies to:
Rukobia
Number of uses:
One rebate per prescription fill

Form more information phone: 866-747-1170 or Visit website

RukobiaeVoucherRx Program

Eligible commercially insured patients may save up to $7500 per year with no monthly limit when filling their prescription as a participating pharmacy; for additional information contact the program at 844-588-3288.

Applies to:
Rukobia
Number of uses:
Per prescription per year

Form more information phone: 844-588-3288 or Visit website

Patient Assistance & Copay Programs for Rukobia

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Rukobia (fostemsavir) Tablet; Extended Release

More information please phone: 866-316-7263 Visit Website

Provider: HarborPath ADAP Waiting List Program

Eligibility requirements:
  1. Must be uninsured
  2. Determined case by case
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US resident.
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. Patients are eligible for the HarborPath ADAP Waiting List Program if they: Meet eligibility for the ADAP Waiting List Program in their state of residency; and have a confirmation letter from their state ADAP indicating patient is on the ADAP waiting list. Typical eligibility requirements do not apply to the ADAP Waiting List Program.
Applicable drugs:
  • Rukobia (fostemsavir) Tablet; Extended Release

More information please phone: 855-300-8916 Visit Website

Provider: ViiV Connect

Eligibility requirements:
  1. *Contact program for details.
  2. At or below 500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must live in US, DC or Puerto Rico
  5. *Contact ViiV Connect for additional information at (844) 588-3288 or www.viivconnect.com Medicare Part B, Part D and Medicare Advantage plan patients who need medicine that same day should ask their Patient Representative (ie, anyone involved in the delivery of the patient's healthcare and is not a family member or friend) to enroll them in ViiV Healthcare PAP by phone. Patients enrolled in a Medicare Part B, Part D and Medicare Advantage prescription drug plan must apply via mail or fax and be found eligible before medicine can be shipped.
Applicable drugs:
  • Rukobia (fostemsavir) Tablet; Extended Release

More information please phone: 844-588-3288 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.